Perrigo Company PLC $153.89

down -0.75


30/7/2014 04:04 PM  |  NYSE : PRGO  
Industries : Drugs / Drug Related Products
Get Trend Analysis Icon Get PRGO Trend Analysis - it has outperformed the S&P 500 by 5%

Partner Headlines

  1. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  2. Worst Performing Industries For July 15, 2014

    Benzinga
  3. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  4. Perrigo Rumored To Be On Block; 'Market Source' Sees 25% Premium

    Benzinga
  5. Worst Performing Industries For July 14, 2014

    Benzinga
  6. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  7. #PreMarket Primer: Monday, June 30: U.S. Data To Confirm Second Quarter ...

    Benzinga
  8. Teva Pharmaceutical

    IBD
  9. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
  10. UPDATE: Perrigo Announces FDA Approval for Generic Version of Astepro

    Benzinga
  11. Perrigo missed EPS views

    IBD
  12. Stocks Hitting 52-Week Lows

    Benzinga
  13. Earnings Scheduled For May 7, 2014

    Benzinga
  14. AstraZeneca Nixes New Bid As Pfizer Woos British PM

    IBD
  15. #PreMarket Primer: Monday, April 7: World Bank Lowers China's 2014 Growth ...

    Benzinga
  16. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  17. 5 Healthcare Stocks With The Highest EPS

    Benzinga
  18. Perrigo Announces Launch Of Authorized Generic Version Of Taclonex Ointment

    Benzinga
  19. #PreMarket Primer: Tuesday, March 25: Group Of Seven Calls For Tougher ...

    Benzinga
  20. #PreMarket Primer: Monday, March 24: NATO Commander Warns Russia Could ...

    Benzinga
  21. Horizon Buys Ireland's Vidara

    IBD
  22. Horizon Pharma To Buy Vidara, Join Exodus To Ireland

    IBD
  23. Horizon Inks $660M Reverse Merger With Ireland's Vidara

    FoxBusiness
  24. Chipotle Mexican Grill Near Buy Point On Pullback

    IBD
  25. #PreMarket Primer: Monday March 10: Russia Tightens Its Grip On Crimea

    Benzinga
  26. Biogen Idec Keeps Momentum Going With MS Drug Tecfidera

    IBD
  27. UPDATE: Morgan Stanley Reiterates On Perrigo Company Following Solid Analyst ...

    Benzinga
  28. #PreMarket Primer: Wednesday, February 26: Bitcoin Faces Another Major ...

    Benzinga
  29. Stocks Rise, End Near Highs

    IBD
  30. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  31. Stocks Close Broadly Higher But Volume Declines

    IBD
  32. Stocks Near Highs In Afternoon; Disney, O'Reilly Jump

    IBD
  33. Earnings Scheduled For February 6, 2014

    Benzinga
  34. Green Mtn., Michael Kors Lead IBD 50's Top 5 Earnings

    IBD
  35. David Rolfe Comments on Perrigo

    GuruFocus
  36. #PreMarket Primer: Monday, January 27: Markets Open The Week On Edge

    Benzinga
  37. Perrigo Receives FDA Final Approval For Generic Equivalent To Prandin

    Benzinga
  38. Drug Buyouts On The Rise -- But Buyers Changing

    IBD
  39. Biogen, Celgene Lead 5 Top Large-Cap Drugmakers

    IBD
  40. Perrigo Seeks New Products, Markets Via Acquisitions

    IBD
  41. Investors Stick With Health Care Stocks

    FoxBusiness
  42. Actavis, Perrigo Pace Strong Generic Drugs Group

    IBD
  43. Stock Market Closes Mixed; More Medicals Break Out

    IBD
  44. UPDATE: Bank of America Upgrades Perrigo

    Benzinga
  45. Benzinga's Top #PreMarket Losers

    Benzinga
  46. #PreMarket Primer: Thursday, December 26: Nikkei Climbs To New Highs

    Benzinga
  47. Stocks Slip Ahead Of Fed; MasterCard Hits New High

    IBD
  48. #PreMarket Primer: Tuesday, December 17: US Markets Rebound Overnight

    Benzinga
  49. Weekly Insider Sells Highlight: ROC, PRGO, JCI, TEL, DISH

    GuruFocus
  50. Weekly CFO Sells Highlight: FleetCor Technologies Inc., Facebook Inc. ...

    GuruFocus
Trading Center